Keyword: Nocion Therapeutics
Julie Grant is the fourth woman to join Canaan’s ranks of general partners. She joins Maha Ibrahim, Nina Kjellson and Wende Hutton.
The public markets have been receptive to early-stage biotechs but will the IPO remain open? We asked our Fierce 15 winners what they thought.
While whole shoals of biotechs are clustered around single cancer targets, Nocion is away from the pack working on better ways to treat conditions such as cough and itch.
